Cytotoxic Effects of Ellagitannins Isolated from Walnuts in Human Cancer Cells

REFERENCES

• American Cancer Society:http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2013/index
   Google Scholar
• Lacroix M, Toillon RA, and Leclercq G: p53 and breast cancer, an update. Endocr Relat Cancer 13, 293–325, 2006.
   PubMed Web of Science ®Google Scholar
• Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, et al.: Molecular portraits of human breast tumours. Nature 406, 747–752, 2000. doi:10.1038/35021093
   PubMed Web of Science ®Google Scholar
• Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, et al.: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proceedings of the National Academy of Sciences of the United States of America 98, 10869–10874, 2001. doi:10.1073/pnas.191367098
   PubMed Web of Science ®Google Scholar
• Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3, 768–780, 2003.
   PubMed Web of Science ®Google Scholar
• Chen CY and Blumberg JB: Phytochemical composition of nuts. Asia Pacific Journal of Clinical Nutrition 17, 329–332, 2008.
   PubMed Web of Science ®Google Scholar
• Feldman EB: The scientific evidence for a beneficial health relationship between walnuts and coronary heart disease. Journal of Nutrition 132, 1062S–1101S, 2002.
   PubMed Web of Science ®Google Scholar
• Anderson KJ, Teuber SS, Gobeille A, Cremin P, Waterhouse AL, et al.: Walnut polyphenolics inhibit in vitro human plasma and LDL oxidation. J Nutr 131, 2837–2842, 2001.
   PubMed Web of Science ®Google Scholar
• Hardman WE and Ion G: Suppression of implanted MDA-MB 231 Human breast cancer growth in nude mice by dietary walnut. Nutrition and Cancer 60, 666–674, 2008. doi:10.1080/01635580802065302
   PubMed Web of Science ®Google Scholar
• Yang J, Liu RH, and Halim L: Antioxidant and antiproliferative activities of common edible nut seeds. LWT-Food Science and Technology 42, 1–8, 2009. doi:10.1016/j.lwt.2008.07.007
   Web of Science ®Google Scholar
• Carvalho M, Ferreira PJ, Mendes VS, Silva R, Pereira JA, et al.: Human cancer cell antiproliferative and antioxidant activities of Juglans regia L. Food and Chemical Toxicology 48, 441–447, 2010. doi:10.1016/j.fct.2009.10.043
   PubMed Web of Science ®Google Scholar
• Grace MH, Warlick CW, Neff SA, and Lila MA: Efficient preparative isolation and identification of walnut bioactive components using high-speed counter-current chromatography and LC-ESI-IT-TOF-MS. Food Chemistry 158, 229–238, 2014. doi:10.1016/j.foodchem.2014.02.117
   PubMed Web of Science ®Google Scholar
• Mullen P: Flow cytometric DNA analysis of human cancer cell lines. Methods in Molecular Medicine 88, 247–255, 2004.
   PubMedGoogle Scholar
• Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680–685, 1970.
   PubMed Web of Science ®Google Scholar
• Chow S And Hedley D: Flow Cytometric Measurement Of Intracellular Ph. Current Protocols in Cytometry Unit 9.3, 2001. doi: 10.1002/0471142956.cy0903s14
   Google Scholar
• Limer JL and Speirs V: Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Research 6, 119–127, 2004. doi:10.1186/Bcr781
   PubMed Web of Science ®Google Scholar
• Regueiro J, Sanchez-Gonzalez C, Vallverdu-Queralt A, Simal-Gandara J, Lamuela-Raventos R, et al.: Comprehensive identification of walnut polyphenols by liquid chromatography coupled to linear ion trap-Orbitrap mass spectrometry. Food Chemistry 152, 340–348, 2014. doi:10.1016/j.foodchem.2013.11.158
   PubMed Web of Science ®Google Scholar
• Yadegarynia S, Pham A, Ng A, Nguyen D, Lialiutska T, et al.: Profiling flavonoid cytotoxicity in human breast cancer cell lines: determination of structure-function relationships. Natural Product Communications 7, 1295–1304, 2012.
   PubMed Web of Science ®Google Scholar
• Grana X and Reddy EP: Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11, 211–219, 1995.
   PubMed Web of Science ®Google Scholar
• Schutters K and Reutelingsperger C: Phosphatidylserine targeting for diagnosis and treatment of human diseases. Apoptosis: An International Journal on Programmed Cell Death 15, 1072–1082, 2010. doi:10.1007/s10495-010-0503-y
   PubMed Web of Science ®Google Scholar
• Reers M, Smith TW, and Chen LB: J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 30, 4480–4486, 1991.
   PubMed Web of Science ®Google Scholar
• Tait SW and Green DR: Mitochondria and cell death: outer membrane permeabilization and beyond. Nature reviews Molecular cell biology 11, 621–632, 2010. doi:10.1038/nrm2952
   PubMed Web of Science ®Google Scholar
• Lagadic-Gossmann D, Huc L, and Lecureur V: Alterations of intracellular pH homeostasis in apoptosis: origins and roles. Cell death and differentiation 11, 953–961, 2004. doi:10.1038/sj.cdd.4401466
   PubMed Web of Science ®Google Scholar
• Mehmet H, Millar JB, Lehmann W, Higgins T, and Rozengurt E: Bombesin stimulation of c-fos expression and mitogenesis in Swiss 3T3 cells: the role of prostaglandin E2-mediated cyclic AMP accumulation. Experimental Cell Research 190, 265–270, 1990.
   PubMed Web of Science ®Google Scholar
• Castano E, Dalmau M, Marti M, Berrocal F, Bartrons R, et al.: Inhibition of DNA synthesis by aspirin in Swiss 3T3 fibroblasts. The Journal of Pharmacology and Experimental Therapeutics 280, 366–372, 1997.
   PubMed Web of Science ®Google Scholar
• von Schwarzenberg K and Vollmar AM: Targeting apoptosis pathways by natural compounds in cancer: marine compounds as lead structures and chemical tools for cancer therapy. Cancer Letters 332, 295–303, 2013. doi:10.1016/j.canlet.2010.07.004
   PubMed Web of Science ®Google Scholar
• Saha SK and Khuda-Bukhsh AR: Molecular approaches towards development of purified natural products and their structurally known derivatives as efficient anti-cancer drugs: current trends. European Journal of Pharmacology 714, 239–248, 2013. doi:10.1016/j.ejphar.2013.06.009
   PubMed Web of Science ®Google Scholar
• Cai Y, Luo Q, Sun M, and Corke H: Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer. Life Sciences 74, 2157–84, 2004. doi: 10.1016/j.lfs.2003.09.047
   PubMed Web of Science ®Google Scholar
• Vanden Heuvel JP, Belda BJ, Hannon DB, Kris-Etherton PM, Grieger JA, et al.: Mechanistic examination of walnuts in prevention of breast cancer. Nutrition and Cancer 64, 1078–1086, 2012. doi:10.1080/01635581.2012.717679
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Nomura M, Murayama T, Furukawa T, Hatano T, et al.: Antitumor activities of ellagitannins against sarcoma-180 in mice. Biological & Pharmaceutical Bulletin 16, 379–387, 1993.
   PubMed Web of Science ®Google Scholar
• Yi ZC, Liu YZ, Li HX, Yin Y, Zhuang FY, et al.: Tellimagrandin I enhances gap junctional communication and attenuates the tumor phenotype of human cervical carcinoma HeLa cells in vitro. Cancer Letters 242, 77–87, 2006. doi:10.1016/j.canlet.2005.10.044
   PubMed Web of Science ®Google Scholar
• Landete JM: Ellagitannins, ellagic acid and their derived metabolites: A review about source, metabolism, functions and health. Food Research International 44, 1150–1160, 2011. doi:10.1016/j.foodres.2011.04.027
   Web of Science ®Google Scholar
• Yamamoto Y and Gaynor RB: Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. The Journal of Clinical Investigation 107, 135–142, 2001. doi:10.1172/JCI11914
   PubMed Web of Science ®Google Scholar
• Chen D, Daniel KG, Chen MS, Kuhn DJ, Landis-Piwowar KR, et al.: Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells. Biochemical Pharmacology 69, 1421–1432, 2005. doi:10.1016/j.bcp.2005.02.022
   PubMed Web of Science ®Google Scholar